SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Natco Pharma submits analyst meet intimation

09 Nov 2023 Evaluate
Natco Pharma has informed that the Company will host an Earnings Call with Investors / Analysts at 11.00 am IST on Wednesday, 15th November 2023 to disseminate Financial Results of the Company for the quarter and half year ended on 30th September 2023. Copy of the same is enclosed for ready reference.

The above information is a part of company’s filings submitted to BSE.

Natco Pharma Share Price

985.90 24.45 (2.54%)
10-Jul-2026 15:24 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1936.85
Dr. Reddys Labs. 1245.00
Cipla 1441.00
Zydus Lifesciences 1149.85
Lupin 2495.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: